ReviewKorean journal of neurotrauma2025
Intramedullary Neural Stem Cell Transplantation in Spinal Cord Injury: Timing, Targets, and Techniques.
Review in Korean journal of neurotrauma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Translational stem cell therapy for neurodegeneration and CNS trauma: a focused review.Molecular biology reports · 2026Review
- A review of the circadian regulation of stem cells: harnessing the internal body clock for enhanced regenerative therapies.Stem cell research & therapy · 2026Review
- Needle gauge and length effects on human stem cell viability during injection: a comprehensive review.Frontiers in cell and developmental biology · 2026Review
- Current status of neural progenitor/stem cells for spinal cord injury: fundamental research and clinical trials.Frontiers in neurologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spinal cord injury remains one of the most challenging neurological disorders due to limited intrinsic regeneration. Neural stem cell (NSC) transplantation offers a promising strategy for restoring neural circuitry and functional recovery. Among delivery methods, direct intramedullary transplantation provides the most localized graft placement and has shown encouraging safety and efficacy in early clinical trials. This review summarizes current evidence and technical considerations for intramedullary NSC transplantation. Key factors influencing outcomes include timing after injury, cell source, surgical approach, and host microenvironment. Advances in microsurgical delivery techniques and biomaterial scaffolds have improved graft survival and integration while minimizing procedure-related risks. Clinical data demonstrate that intramedullary NSC transplantation is feasible and generally safe, with early signals of motor improvement. Nevertheless, challenges remain in achieving consistent cell engraftment and long-term functional gains. Future work should focus on refining transplantation parameters, establishing standardized surgical protocols, and conducting multicenter trials with long-term follow-up to confirm clinical efficacy. By integrating current findings, this review provides a concise overview of surgical evolution and translational progress, highlighting intramedullary NSC transplantation as a key frontier in regenerative spinal surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.